TP53 and medulloblastoma: The same group has also opened a specific stratum for patients with TP53-mutated SHH medulloblastoma, as these patients have been identified to have a particularly poor prognosis, with a significant proportion of these tumors occurring in the context of Li–Fraumeni syndrome [58,59].